Page 298 - Biodegradable Polyesters
P. 298

276  11  Electrospun Biopolymer Nanofibers and Their Composites for Drug Delivery Applications

                    from electrospun nanofibers can be finely tuned by controlling the crystallinity,
                    glass transition temperature (T ) of the polymer, and hydrophilicity or hydropho-
                                             g
                    bicity of the drug, as well as the binding affinity between the drug and polymer
                    matrix [11–13].
                      Electrospinning affords great flexibility in selecting materials for drug delivery
                    applications; either biodegradable or nondegradable materials can be used to
                    control drug release via diffusion alone or diffusion and scaffold degradation.
                    In addition, a number of drugs can be delivered owing to the flexibility in
                    material selection, including antibiotics, anticancer drugs, proteins, and DNA.
                    Combined with various electrospinning techniques, a variety of different drug
                    loading methods can be utilized to give finer control over drug release kinetics,
                    such as embedded drugs, coatings, and encapsulated drugs (e.g., coaxial and
                    emulsion electrospinning). Therefore, this chapter concerns the recent progress
                    in drug delivery systems of electrospun drug/biopolymer composites with simply
                    blended or uniquely encapsulated structures, which can be achieved by conven-
                    tional electrospinning of drug/biopolymers or nanoparticle/biopolymer blends,
                    core–shell (coaxial and emulsion) electrospinning, or electrospraying method.
                    Moreover, selected biomedical applications of the aforementioned electrospun
                    drug/biopolymer composites will be broadly presented with controlled release
                    properties, such as wound dressings, devices, and scaffolds for localized delivery
                    of chemotherapeutics.



                    11.2
                    Simply Blended Drug/Biopolymer Nanofibers by Conventional Electrospinning for
                    Drug Delivery

                    Electrospinning was first applied for patents by Formhals [14] in 1934, where an
                    experimental setup for generating polymer filaments was introduced. Figure 11.1
                    shows a schematic illustration of the basic setup for electrospinning, which con-
                    sists of three major modules: a high-voltage power generator, a syringe pump
                    (syringe included), and a collector [15]. Polymer solution hosted in the syringe

                       Electrospinning  High voltage power supply

                                                        Nanofibers
                                            15 kV
                           Syringe pump




                                                                     Collector
                                    Polymer solution
                    Figure 11.1 Schematic illustration of the basic electrospinning setup. (Reproduced with
                    permission from Ref. [15]; Copyright 2012 American Chemical Society.)
   293   294   295   296   297   298   299   300   301   302   303